Light and diabetic eye disease
| ISRCTN | ISRCTN34037927 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN34037927 |
| Protocol serial number | 08/H0808/198 |
| Sponsor | King's College Hospital NHS Trust (UK) |
| Funder | Internal funding |
- Submission date
- 30/10/2009
- Registration date
- 30/11/2009
- Last edited
- 11/12/2013
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Miss Sobha Sivaprasad
Scientific
Scientific
Dept. Ophthalmology
King's College Hospital NHS Trust
Denmark Hill
London
SE5 9RS
United Kingdom
| Phone | +44 (0)20 3299 3385 |
|---|---|
| senswathi@aol.com |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Single centre randomised single blinded controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | The effect of prevention of Dark Adaptation (DA) on the progress of Diabetic Macular oEdema (DME) |
| Study acronym | DA and DME |
| Study objectives | By reducing the metabolic demand of retinal rods, which is maximal in dark adaptation, retinal hypoxia in diabetic eye disease will be reduced, and the progress of diabetic eye disease reversed. |
| Ethics approval(s) | Approved by Kings College Hospital Research Ethics Committee (REC) in February 2009 (ref: 08/H0808/198) |
| Health condition(s) or problem(s) studied | Diabetic retinopathy |
| Intervention | Patients will sleep wearing a device ('light mask') that illuminates one (closed) eyelid. The eye is chosen at random. The other eye acts as control. Each patient will be treated for 6 months |
| Intervention type | Other |
| Primary outcome measure(s) |
1. Ocular coherence tomography (OCT) |
| Key secondary outcome measure(s) |
None |
| Completion date | 01/05/2010 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Upper age limit | 65 Years |
| Sex | All |
| Target sample size at registration | 40 |
| Key inclusion criteria | 1. Adults age 18-65 2. No systemic disease apart from diabetes (type I or II) 3. Symmetrical DME which cannot be treated surgically, or does not require immediate intervention |
| Key exclusion criteria | 1. Any other systemic disease or severe diabetic complication 2. Any other eye condition except refractive error of > 5 D 3. History of any psychological disturbance 4. Persons of no fixed abode 5. Sleep apnoea. 6. Inability to tolerate the device, or difficulty in sleeping wearing the device. |
| Date of first enrolment | 01/03/2009 |
| Date of final enrolment | 01/05/2010 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Dept. Ophthalmology
London
SE5 9RS
United Kingdom
SE5 9RS
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/12/2011 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |